[Hopespringpcsg] FW: Pazopanib Tops Temsirolimus in Intermediate-Risk RCC

[Glen Tolhurst]

Hi all:

See 2nd article below.

Thx.

Glen

 

From: Cancer Network [mailto:cancernetwork at email.cmpmedica-usa.com] 
Sent: February 15, 2018 10:32 AM
To: glen46nor at gmail.com
Subject: Pazopanib Tops Temsirolimus in Intermediate-Risk RCC

 

Plus: Adjuvant vs salvage radiotherapy in high-risk prostate cancer


To view this email as a web page, click
<http://view.email.cmpmedica-usa.com/?qs=2c96db2274c22ced26aa491eb211b83928c
0be30b67e26577547b2e46ed1146beb34c00953bf96b92af36f6214574c8d82e15ad90628ab6
d462c6146114d6e13f256da1123712a77f34c27da99bc2c57> here.




 Modern Medicine Network
<http://www.ubmmedica.com/wp-content/uploads/2016/11/ModernMedicineNetwork-s
mall.png> 

 


 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab92376f5977cba0d1b20073e
81e1fd04e44ee7e990ec0a978e3d7764f607faddf0ef04d1b59b0cb59838b8> Cancer
Network

 


HIGHLIGHTS   |  February 15, 2018 

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab9237669bf9f8a4d72b12446
abc03cd9129d9b6ea22339a17d71209e5b98546b0bdc630f4751bccbd048fd> Pazopanib
Tops Temsirolimus in Intermediate-Risk Clear Cell RCC 



Pazopanib was not associated with prolonged progression-free survival
compared with temsirolimus among patients with advanced clear-cell renal
cell carcinoma, but a subgroup analysis of intermediate-risk patients
offered some reason for optimism.

 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab9237676b674f189b74a7f08
f61d97bf5ed34f4a506768c2b1bdd924f703984a427817662192acce9606a8>  Read more  

	

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab923769a1458708ab402d3ba
62fccd78b3461a5246d30b4474684e3db783564a50f589b36059aa73c3d47f> Adjuvant vs
Salvage Radiotherapy in High-Risk Prostate Cancer 



Adjuvant radiotherapy after prostatectomy resulted in lower rates of
biochemical recurrence, distant metastases, and death compared with
surveillance followed by early-salvage radiotherapy in patients with
high-risk prostate cancer, according to a new study.

 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab923769a1458708ab402d3ba
62fccd78b3461a5246d30b4474684e3db783564a50f589b36059aa73c3d47f>  Read more  

	

 


  



TEST YOUR IMAGE IQ 

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab92376fafb9ab0208dd83ad9
64b50e0afc8ed99775c6c2e4103b9d12f24234e99c3e7e8855a6813dbd6034> Mass Found
in Adrenal Gland of 52-Year-Old Patient 



 
<http://content.ubmlifesciences.com/sites/default/files/styles/media_thumbna
il/public/moran-adrenal-52-20180208.jpg> Cesar A. Moran, MD
A 52-year-old man presents with a mass in his right adrenal gland, and a
biopsy is performed. 


What is the diagnosis?
A. Adrenocortical hyperplasia
B. Angiosarcoma
C. Hemorrhagic pseudocyst
D. Addison disease 


 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab923764b25e2339406db5bcf
a0a3df18ac2cb3427402491ee46edf2c81631a29d7283299761d5e77712013>  Click here
to choose your answer  

 


  

 



This is a post-only, outbound email. Please do not reply to this email as we
will be unable to respond to your reply. Please use the links provided if
you have questions or concerns regarding this email or your subscription.




  <http://images.ubmmedica.com/ubm-logo-newsletter-2017-white.png> 

This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA

 


NEWSLETTER

 
<http://view.email.cmpmedica-usa.com/ftaf.aspx?qs=2c96db2274c22ced26aa491eb2
11b83928c0be30b67e26577547b2e46ed1146b979f88236806720d9e02518ce0b5eff9>
Forward to a Friend 
 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab923764650dbd7a5ffa9e530
3a0faf029b63fdb50cf5e663aa8828bce62976ff5481e37a05753aa358e8cb> Privacy
Statement
 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab92376c92c5f1366961086f5
b1262a15a558c096eab43d09f5909cbb11a62085010cfd01c7fa9d0c150324> Terms of
Service
 
<http://click.email.cmpmedica-usa.com/profile_center.aspx?qs=a2b941f134a4276
3c587af15301dc42e736c79925b42e448e208a5ee1cd0bb08e32c85d343ae334e4d5ba42bf1c
463371fb887c17e75b3a2ac54b8db1036cf17824eb14d21e955dd> Update Profile
 
<http://click.email.cmpmedica-usa.com/profile_center.aspx?qs=a2b941f134a4276
3c587af15301dc42e736c79925b42e448e208a5ee1cd0bb08e32c85d343ae334e4d5ba42bf1c
463371fb887c17e75b3a2ac54b8db1036cf17824eb14d21e955dd> Add/Remove
Newsletters
 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab923764f65f8137f5689d357
5123ce011b1fdea1d42dd2b62f5dc965fd66ace0a47d2f34798e3617179c81> Subscribe to
Print
 <mailto:editorial at hcl.com> Contact Us 


CONNECT

 
<http://click.email.cmpmedica-usa.com/?qs=72cd67765ab9237624c2a1b77c17563800
e58fc57463a05369ea282b8216bd552e0809777fdb60af2d4368bc5e0201ab> Twitter
<http://click.email.cmpmedica-usa.com/?qs=e1933b43a139c68afe84b80a868b58a654
07c403f0f1f0459d321461da9186d8a64049782d223a4e23734c431678d7bc> Facebook
<http://click.email.cmpmedica-usa.com/?qs=e1933b43a139c68a4920788c1ace9bcb1c
dfdaff52c599e2901c6ed7a0ebee731c9747ba6e612880f10f81a5d005d614> LinkedIn
<http://click.email.cmpmedica-usa.com/?qs=e1933b43a139c68aada2d90b80b4563a86
35026e9c6c6d5760e41f9aa5f49333704853a05e110f21525d6c5330ab01f3> RSS


  

 
<http://click.email.cmpmedica-usa.com/open.aspx?ffcb10-fe5e16797d65047a7512-
fdc515707361077f7c12737761-feca15707d60027f-fe9b1574706c067d75-fdf0157571650
4757d12757c-ffcf14> 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180215/3c3c2735/attachment-0001.html>